John H. Barton

1.1k citations
32 papers · 885 indexed · h-index 15
Topics
Cancer Treatment and Pharmacology (12 papers)HER2/EGFR in Cancer Research (9 papers)Lung Cancer Treatments and Mutations (7 papers)

In The Last Decade

John H. Barton

31 papers receiving 858 citations

Peers

John H. Barton
Comparison fields: 5 of 60
  • Oncology 526
  • Pathology and Forensic Medicine 350
  • Pulmonary and Respiratory Medicine 284
  • Genetics 244
  • Molecular Biology 180
Replace James E. Bradof with:
James E. Bradof United States
Don W. Shaffer United States
Dianna Shipley United States
Oliver Rosen United States
Lydia Sánchez-Verde Spain
Marta Orsenigo Italy
Cinta Hierro Spain
Xiaopei Zhu United States
J.P. Delord France
Soo Kee Min South Korea
John H. Barton relative to James E. Bradof United States James E. Bradof's profile →
Citations per field
00.5×4.8×
James E. Bradof · 1×
Citations per year

Countries citing papers authored by John H. Barton

Since Specialization
Citations

This map shows the geographic impact of John H. Barton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John H. Barton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John H. Barton more than expected).

Fields of papers citing papers by John H. Barton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John H. Barton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John H. Barton. The network helps show where John H. Barton may publish in the future.

Co-authorship network of co-authors of John H. Barton

This figure shows the co-authorship network connecting the top 25 collaborators of John H. Barton. A scholar is included among the top collaborators of John H. Barton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John H. Barton. John H. Barton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 22
3 32
4 24
5 5
6 5
7 14
8 21
9 12
10 5
11 11
12 25
13 8
14 30
15 36
16 6
17 5
18 6
19 85
20 123

About John H. Barton

John H. Barton is a scholar working on Oncology, Cancer Research and Hematology, having authored 32 papers that have together received 885 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (12 papers), HER2/EGFR in Cancer Research (9 papers) and Lung Cancer Treatments and Mutations (7 papers). The work is most often cited by research in Genetics (244 citations), Pathology and Forensic Medicine (350 citations) and Oncology (526 citations). John H. Barton has collaborated with scholars based in United States, United Kingdom and Japan. Frequent co-authors include John D. Hainsworth, F. Anthony Greco, Sharlene Litchy, James E. Bradof, Howard A. Burris, Gerry Ann Houston, Robert C. Hermann, David R. Spigel, Lisa H. Morrissey and Dianna Shipley. Their work appears in journals such as Journal of Clinical Oncology, Blood and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026